West Pharmaceutical Services (WST) : Copper Rock Capital Partners scooped up 5,322 additional shares in West Pharmaceutical Services during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 19, 2016. The investment management firm now holds a total of 343,847 shares of West Pharmaceutical Services which is valued at $26,985,113.West Pharmaceutical Services makes up approximately 1.97% of Copper Rock Capital Partners’s portfolio.
Other Hedge Funds, Including , First National Bank Of Omaha reduced its stake in WST by selling 2,550 shares or 17.06% in the most recent quarter. The Hedge Fund company now holds 12,400 shares of WST which is valued at $973,152. West Pharmaceutical Services makes up approx 0.07% of First National Bank Of Omaha’s portfolio.Ruane Cunniff Goldfarb Inc reduced its stake in WST by selling 90,631 shares or 16.98% in the most recent quarter. The Hedge Fund company now holds 443,019 shares of WST which is valued at $34,311,822. West Pharmaceutical Services makes up approx 0.32% of Ruane Cunniff Goldfarb Inc’s portfolio.Gw&k Investment Management reduced its stake in WST by selling 19,651 shares or 1.67% in the most recent quarter. The Hedge Fund company now holds 1,160,527 shares of WST which is valued at $90,428,264. West Pharmaceutical Services makes up approx 1.84% of Gw&k Investment Management’s portfolio.
West Pharmaceutical Services opened for trading at $78.23 and hit $78.9 on the upside on Wednesday, eventually ending the session at $78.48, with a gain of 1.34% or 1.04 points. The heightened volatility saw the trading volume jump to 3,44,193 shares. Company has a market cap of $5,735 M.
On the company’s financial health, West Pharmaceutical Services reported $0.53 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.51. The company had revenue of $362.10 million for the quarter, compared to analysts expectations of $356.32 million. The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.45 EPS.
West Pharmaceutical Services Inc. is a manufacturer of components and systems for the packaging and delivery of injectable drugs as well as delivery system components for the pharmaceutical healthcare and consumer products industries. The Company’s products include stoppers and seals for vials prefillable syringe components and systems components for intravenous and blood collection systems safety and administration systems advanced injection systems and contract design and manufacturing services. The Company’s customers include producers of pharmaceuticals biologics medical devices and personal care products. The Company’s reportable segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems).